​

Funding Round

Series C - Bionano Genomics

Series C - Bionano Genomics

Investment Firm

Overview

Bionano Genomics is a biotechnology company that provides genome analysis solutions to researchers and clinicians.

Announced Date

Nov 20, 2014

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Novartis Venture Fund

Novartis Venture Fund

Novartis Venture Fund is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Legend Capital

Legend Capital

Legend Capital is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorLegend Capital
Participant InvestorNovartis Venture Fund
Participant InvestorBattelle Ventures
Participant InvestorDomain Associates
Participant InvestorGund Investment, LLC

Round Details and Background

Bionano Genomics raised $53000000 on 2014-11-20 in Series C

Bionano Genomics is a biotechnology company that provides genome analysis solutions to researchers and clinicians.

Company Funding History

17

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 27, 2010
Debt Financing - Bionano Genomics
-782.3K
Oct 02, 2013
Series C - Bionano Genomics
3-10.0M
Jul 06, 2012
Series B - Bionano Genomics
3-10.0M
Mar 17, 2011
Series B - Bionano Genomics
4-23.3M

Recent Activity

There is no recent news or activity for this profile.